loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X

Technical details about 055E203F-B305-4B7F-8CE7-F9C0C03AB609, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
Also known as: Trans-ferulic acid, 1135-24-6, 537-98-4, 4-hydroxy-3-methoxycinnamic acid, Trans-4-hydroxy-3-methoxycinnamic acid, 3-(4-hydroxy-3-methoxyphenyl)acrylic acid
Molecular Formula
C10H10O4
Molecular Weight
194.18  g/mol
InChI Key
KSEBMYQBYZTDHS-HWKANZROSA-N
FDA UNII
AVM951ZWST

Ferulic acid is a metabolite found in or produced by Saccharomyces cerevisiae.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid
2.1.2 InChI
InChI=1S/C10H10O4/c1-14-9-6-7(2-4-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13)/b5-3+
2.1.3 InChI Key
KSEBMYQBYZTDHS-HWKANZROSA-N
2.1.4 Canonical SMILES
COC1=C(C=CC(=C1)C=CC(=O)O)O
2.1.5 Isomeric SMILES
COC1=C(C=CC(=C1)/C=C/C(=O)O)O
2.2 Other Identifiers
2.2.1 UNII
AVM951ZWST
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-(4-hydroxy-3-methoxyphenyl)-2-propenoic Acid

2. 4-hydroxy-3-methoxycinnamic Acid

3. 8,8'-diferulic Acid

4. Cis-ferulic Acid

5. Ferulic Acid, (e)-isomer

6. Ferulic Acid, (z)-isomer

7. Ferulic Acid, Monosodium Salt

8. Sodium Ferulate

9. Trans-ferulic Acid

2.3.2 Depositor-Supplied Synonyms

1. Trans-ferulic Acid

2. 1135-24-6

3. 537-98-4

4. 4-hydroxy-3-methoxycinnamic Acid

5. Trans-4-hydroxy-3-methoxycinnamic Acid

6. 3-(4-hydroxy-3-methoxyphenyl)acrylic Acid

7. (e)-ferulic Acid

8. Ferulate

9. Coniferic Acid

10. 2-propenoic Acid, 3-(4-hydroxy-3-methoxyphenyl)-

11. 3-(4-hydroxy-3-methoxyphenyl)-2-propenoic Acid

12. Ferulic Acid, Trans-

13. Fumalic Acid

14. (e)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoic Acid

15. (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic Acid

16. Cinnamic Acid, 4-hydroxy-3-methoxy-

17. 3-methoxy-4-hydroxycinnamic Acid

18. (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic Acid

19. Cinnamic Acid, 4-hydroxy-3-methoxy-, (e)-

20. Mfcd00004400

21. (e)-4-hydroxy-3-methoxycinnamic Acid

22. 2-propenoic Acid, 3-(4-hydroxy-3-methoxyphenyl)-, (2e)-

23. (e)-4'-hydroxy-3'-methoxycinnamic Acid

24. (2e)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoic Acid

25. Cinnamic Acid, 4-hydroxy-3-methoxy-, Trans-

26. 2-propenoic Acid, 3-(4-hydroxy-3-methoxyphenyl)-, (e)-

27. Avm951zwst

28. (e)-3-(4-hydroxy-3-methoxyphenyl)acrylic Acid

29. 97274-61-8

30. (2e)-3-(4-hydroxy-3-methoxyphenyl)acrylic Acid

31. Ferulic Acid Dehydrogenation Homopolymer

32. Fumalic Acid (ferulic Acid)

33. 4-hydroxy-3-methoxycinnamate

34. Chembl32749

35. 3-(4-hydroxy-3-methoxyphenyl)-2-propenoic Acid Homopolymer

36. Chebi:17620

37. Nsc2821

38. Nsc-2821

39. 3-methoxy-4-hydroxy-trans-cinnamate

40. Nsc-51986

41. (e)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic Acid

42. (e)-ferulate

43. 3-(4-hydroxy-3-methoxyphenyl)propenoic Acid

44. Trans-ferulic Acid (purified By Sublimation)

45. Cinnamic Acid,4-hydroxy,3-methoxy Ferulic Acid

46. Caffeic Acid 3-methyl Ether

47. 2-propenoic Acid, 3-(4-hydroxy-3-methoxyphenyl)-, Homopolymer

48. 3-methoxy-4-hydroxy-trans-cinnamic Acid

49. Smr000112202

50. 4-hydroxy-3-methoxy Cinnamic Acid

51. Einecs 208-679-7

52. Unii-avm951zwst

53. Ferulic Acid (trans-4-hydroxy-3-methoxycinnamic Acid)

54. Ferulasaure

55. Trans-ferulate

56. (e)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate

57. Ccris 3256

58. Ccris 7127

59. Ccris 7575

60. Hsdb 7663

61. Trans-ferulicacid

62. Nsc-674320

63. Nsc 2821

64. Ferulic Acid, E-

65. Einecs 214-490-0

66. Nsc 51986

67. (e)-coniferic Acid

68. Trans-4-hydroxy-3-methoxycinnamicacid

69. Ferulic Acid (m5)

70. Nsc 674320

71. Ferulic Acid ,(s)

72. Ferulic-acid

73. Ferulic Acid, Synthetic

74. Spectrum5_000554

75. Bmse000459

76. Bmse000587

77. Bmse010211

78. Ferulic Acid [mi]

79. Trans-ferulic Acid, 99%

80. Ferulic Acid [hsdb]

81. Ferulic Acid [inci]

82. Schembl15673

83. Bspbio_003168

84. Mls001066385

85. Mls001332483

86. Mls001332484

87. Mls002207079

88. Mls006011435

89. Spectrum1501017

90. Trans-ferulic Acid, >=99%

91. Ferulic Acid [usp-rs]

92. Ferulic Acid [who-dd]

93. Zinc58258

94. Dtxsid70892035

95. Hms1921d05

96. Hms2269p04

97. (e)-4-hydroxy-3-methoxycinnamate

98. Trans-4-hydroxy-3-methoxycinnamate

99. Albb-013505

100. Bcp21231

101. Bcp21789

102. Hy-n0060

103. Nsc51986

104. Str00961

105. (e)-4-hydroxy-3-methoxy-cinnamate

106. Trans-ferulic Acid [who-dd]

107. (e)4-hydroxy-3-methoxycinnamic Acid

108. Ac7905

109. Bbl010345

110. Bdbm50214744

111. Ccg-38860

112. S2300

113. Stk801551

114. Akos000263735

115. Ac-7965

116. Bcp9000163

117. Db07767

118. Ps-3435

119. Sdccgmls-0066667.p001

120. Trans-3-methoxy-4-hydroxycinnamic Acid

121. (e)-4-hydroxy-3-methoxy-cinnamic Acid

122. 3-(4-hydroxy-3-methoxyphenyl)propenoate

123. 4-hydroxy-3-methoxycinnamic Acid, Trans

124. Ncgc00094889-01

125. Ncgc00094889-02

126. Ncgc00094889-03

127. Ncgc00094889-04

128. Ac-10321

129. Bs-17543

130. Smr004703246

131. Am20060784

132. Cs-0007108

133. F1257

134. H0267

135. N1878

136. Sw219616-1

137. C01494

138. A829775

139. Q417362

140. Sr-01000765539

141. (2e)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate

142. J-002980

143. Sr-01000765539-3

144. (e)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoic Acid

145. 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoicacid

146. Ferulic Acid (constituent Of Black Cohosh) [dsc]

147. 055e203f-b305-4b7f-8ce7-f9c0c03ab609

148. 3986a1be-a670-4b06-833b-e17253079fd8

149. Ferulic Acid, European Pharmacopoeia (ep) Reference Standard

150. Trans-ferulic Acid, Certified Reference Material, Tracecert(r)

151. Diethyl2-(acetamido)-2-(2-(bromomethyl)-5-nitrobenzyl)malonate

152. Ferulic Acid, United States Pharmacopeia (usp) Reference Standard

153. Trans-ferulic Acid, Matrix Substance For Maldi-ms, >=99.0% (hplc)

154. 4-hydroxy-3-methoxycinnamic Acid, Mixture Of Isomers, Analytical Reference Material

155. Ferulic Acid, Pharmaceutical Secondary Standard; Certified Reference Material

156. 831-85-6

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 194.18 g/mol
Molecular Formula C10H10O4
XLogP31.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Exact Mass194.05790880 g/mol
Monoisotopic Mass194.05790880 g/mol
Topological Polar Surface Area66.8 Ų
Heavy Atom Count14
Formal Charge0
Complexity224
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

Ferulic acid (FA) is an effective scavenger of free radicals and it has been approved in certain countries as food additive to prevent lipid peroxidation.

PMID:18188410 Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127228 Srinivasan M et al; J Clin Biochem Nutr 40 (2): 92-100 (2007)


Sodium ferulate (SF) or 3-methoxy-4-hydroxy-cinamate sodium is an active principle from Angelica sinensis, Cimicifuga heracleifolia, Lignsticum chuangxiong, and other plants. It has been used in traditional Chinese medicine and is approved by State Drugs Administration of China as a drug for treatment of cardiovascular and cerebrovascular diseases. SF has antithrombotic, platelet aggregation inhibitory and antioxidant activities in animals and humans. For several decades SF has been widely used in China to treat cardiovascular and cerebrovascular diseases and to prevent thrombosis... /Sodium ferulate/

PMID:16007232 Wang BH, Ou-Yang JP; Cardiovasc Drug Rev 23 (2): 161-72 (2005)


/EXPL THER/ Ligusticum Chuanxiong and its effective components were studied in the treatment of ischemic stroke, a common emergent disease in China. Some injections of the medicines, including Ligusticum, Ligustrazine, Ligustylid and ferulic acid, were tested clinically and experimentally. The results showed that the effects of the drugs were the same as or even better than those of the controls, such as papaverine, dextran and aspirin-persantin. They could improve brain microcirculation through inhibiting thrombus formation and platelet aggregation as well as blood viscosity.

PMID:1291208 Chen KJ, Chen K; Chin Med J (Engl). 105 (10): 870-3 (1992)


/EXPL THER/ Although more definitive research is necessary, several natural therapies show promise in treating hot flashes without the risks associated with conventional therapies. Soy and other phytoestrogens, black cohosh, evening primrose oil, vitamin E, the bioflavonoid hesperidin with vitamin C, ferulic acid, acupuncture treatment, and regular aerobic exercise have been shown effective in treating hot flashes in menopausal women.

PMID:12946239 Philip HA; Altern Med Rev 8 (3): 284-302 (2003)


For more Therapeutic Uses (Complete) data for FERULIC ACID (6 total), please visit the HSDB record page.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


Free Radical Scavengers

Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)


Cholagogues and Choleretics

Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)


Anticoagulants

Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)


Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


Indicators and Reagents

Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh's Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)


5.2 Absorption, Distribution and Excretion

The study described here has investigated the bioavailability of ferulic acid in humans, from tomato consumption, through the monitoring of the pharmacokinetics of excretion in relation to intake. The results show that the peak time for maximal urinary excretion is approximately 7 hr and the recovery of ferulic acid in the urine, on the basis of total free ferulic acid and feruloyl glucuronide excreted, is 11-25% of that ingested.

Bourne LC, Rice Evans C; Biochem Biophys Res Commun 253 (2): 222-7 (1999)


The ... study investigated the urinary excretion of free and conjugated ferulic acid, present in quantitatively detectable amounts in French maritime pine (Pinus maritima) bark extract (PBE), after oral PBE administration to human subjects. Eleven healthy adult subjects (4 women and 7men) consumed either a single dose (200 mg PBE) or two doses of PBE (100 and 200 mg, respectively) within a 48-hr interval. Two days before the oral administration of PBE and during the urine sample collection period volunteers adhered to a diet low in polyphenols. Aliquots of all urine production were collected over 24 hr. Free and conjugated ferulic acid was assessed in urine by HPLC using diode array detection. A close association between the dietary intake of PBE and the urinary excretion of ferulic acid was detected. Moreover, the results indicate that a considerable proportion of ferulic acid is excreted as glucuronide or sulfate after PBE consumption, varying over the range 2 to 20% between individuals. The kinetics of excretion associated with the administration of 100 mg PBE was quite similar to that obtained after 200 mg PBE. A biphasic trend was evident in a number of subjects. All subjects studied here displayed a significant, although variable level of excretion of ferulic acid after supplementation with PBE, Thus, the data provide evidence that at least a part of the phenolic components of PBE are absorbed, metabolized, and eliminated by humans.

Virgili F et al; Free Radic Biol Med 28 (8): 1249-56 (2000) :


The hydroxycinnamates, intermediates in the phenylpropanoid synthetic pathway, are effective in enhancing the resistance of low-density lipoprotein (LDL) to oxidation in the order caffeic acid greater than ferulic acid greater than p-coumaric acid. It is unclear whether the mode of action of ferulic acid as an antioxidant is based on its activities in the aqueous or the lipophilic phase. Partitioning of 14C-labelled ferulic acid into plasma and its components, LDL and the albumin-rich fractions, has been studied under conditions of maximum aqueous solubility. The majority of ferulic acid associates with the albumin-rich fraction of the plasma, although a proportion is also found to partition between the LDL and aqueous phases; however, ferulic acid does not associate with the lipid portion of the LDL particle, suggesting that it exerts its antioxidant properties from the aqueous phase. This is of particular interest since the results demonstrate that ferulic acid is a more effective antioxidant against LDL oxidation than the hydrophilic antioxidant ascorbic acid.

Castelluccio C et al; Biochem J 316 ( Pt 2)691-4 (1996):


The major constituents of artichoke extracts are hydroxycinnamic acids such as chlorogenic acid, dicaffeoylquinic acids caffeic acid and ferulic acid, and flavonoids such as luteolin and apigenin glycosides. ...Several studies have shown the effect on animal models of artichoke extracts ... . . Results showed a plasma maximum concentration of 6.4 (SD 1.8) ng/mL for chlorogenic acid after 1 hr and its disappearance within 2 hr (P< 0.05). Peak plasma concentrations of 19.5 (SD 6.9) ng/ml for total caffeic acid were reached within 1 h, while ferulic acid plasma concentrations showed a biphasic profile with 6.4 (SD1.5) ng/mL and 8.4 (SD4.6) ng/mL within 1 hr and after 8 hr respectively. ...A significant increase of dihydrocaffeic acid and dihydroferulic acid total levels after 8 hr (P<0.05) /was observed/. No circulating plasma levels of luteolin and apigenin were present.

Azzini E et al; Br J Nutr 97 (5): 963-9 (2007):


5.3 Metabolism/Metabolites

The bioavailability of ferulic acid (FA; 3-methoxy-4-hydroxycinnamic acid) and its metabolites was investigated in rat plasma and urine after an oral short-term ingestion of 5.15 mg/kg of FA. Free FA, glucuronoconjugates, and sulfoconjugates were quickly detected in plasma with a peak of concentration found 30 min after ingestion. Sulfoconjugates were the main derivates ( approximately 50%). In urine, the cumulative excretion of total metabolites reached a plateau 1.5 h after ingestion, and approximately 40% were excreted by this way. Free FA recovered in urine represented only 4.9 +/-1.5% of the native FA consumed by rats. Glucuronoconjugates and sulfoconjugates represented 0.5 +/- 0.3 and 32.7 +/- 7.3%, respectively. These results suggested that a part of FA incorporated in the diet was quickly absorbed and largely metabolized in sulfoconjugates before excretion in urine.

Rondini F et al; J Agric Food Chem 50 (10): 3037-41(2002):


Ferulic acid (FA) is a phytochemical commonly found in fruits and vegetables such as tomatoes, sweet corn and rice bran. It arises from metabolism of phenylalanine and tyrosine by Shikimate pathway in plants.

PMID:18188410 Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127228 Srinivasan M et al; J Clin Biochem Nutr 40 (2): 92-100 (2007)


Ferulic Acid has known human metabolites that include (2S,3S,4S,5R)-6-[4-[(E)-2-carboxyethenyl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


Post Enquiry
POST ENQUIRY